The American-Irish medical devices company disclosed the sum Thursday in its annual 10-K report. The charge was also related to the establishment of a deferred tax asset.
The group recorded an additional $66 million cost related to the amortization of previously established deferred tax assets from intercompany IP transactions.
Medtronic’s reconciliation of income taxes showed intercompany transactions reduced its effective tax rate by $165 million in Ireland, while increasing it by $278 million in the ...
Learn more about Bloomberg Tax or Log In to keep reading:
See Breaking News in Context
From research to software to news, find what you need to stay ahead.
Already a subscriber?
Log in to keep reading or access research tools and resources.
